We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Protherics | LSE:PTI | London | Ordinary Share | GB0007029209 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 45.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2008 15:43 | Martinfrench bet your glad you bailed 40p on the ask and still looking to fall 20 % further this week. | bargainbob | |
29/9/2008 14:04 | REDNINJA Gooodfor both parties to go alone just now. | bargainbob | |
29/9/2008 13:22 | i am out, threw it into lloyds at 216.5 | martinfrench | |
29/9/2008 12:43 | Bargainbob, Lets hope BTG pulls out and pays PTI £2 million | red ninja | |
29/9/2008 12:38 | Martinfrench hope you got out before the main fall. | bargainbob | |
29/9/2008 10:08 | Yes, Either side can pull out at a cost of £2 million payable to the other party. | bargainbob | |
29/9/2008 10:04 | Does anybody know if there is a 'get out' clause for PTI if the BGC price continues to fall? | fhmktg | |
29/9/2008 09:12 | i dont the board in charge of protherics, they should have had a duty to report the other offer, but havn't, the city is losing so much trust i would be surprised if anyone invests for next couple of years | martinfrench | |
29/9/2008 09:09 | Martin french Be quick BTG is off a lot this morning, PTI has not followed yet. | bargainbob | |
29/9/2008 09:03 | its really tempting, in fact i will sell today, disgusted by this deal, what a rip off and quite clever for btg as they used their overly inflated share price. | martinfrench | |
29/9/2008 08:42 | Expect 40p today is on the cards. | bargainbob | |
28/9/2008 23:16 | After 15 years with PTI, I sold my lot. Couldn't bear to see it fall so low in value. Good luck everyone, we should have been sold over a £1.00 at the very least. | bobby.ifa | |
28/9/2008 15:22 | BargainBob, I agree with you, but we're dreaming. Unfortunately the pearl PTI is saddled with that loser BTG. | red ninja | |
28/9/2008 12:28 | Big fall off on Friday in PTI as BTG went up. Hope they are pulling out of this badly timed deal. | bargainbob | |
26/9/2008 15:05 | Yes, these things are usually a done deal with the institutions and big investors. Small PIs like me don't bother to vote as my nominee holder charges me for the privilage. Anyway if it fell through in current times I'm afraid we would be back to 30p toute suite... | red ninja | |
26/9/2008 14:45 | Am I the only shareholder who thinks that this deal will not go through? | gregsc | |
26/9/2008 12:03 | Hope so , this would be goog news long t erm for BTG. | bargainbob | |
26/9/2008 11:55 | Nomura still buying at 45p Are they expecting a counter offer? Is this a done deal? | fhmktg | |
26/9/2008 11:05 | Long term I agree , but look at the chart a perfect head and shoulders is forming. Better to sell today and get back in at 115-125 within the next few weeks. | bargainbob | |
26/9/2008 10:43 | Bob, looking at the Piper Jaffrey notes on both, they see fair value on BGC 242p exc V, and 67p for PTI, the basic maths gives 238p, add in the £20m annual cost saving and synergies you come out with a fair value of well over £3. The period post a bid on this scale is always like this, I am sure this deal is excellent and the business will grow into a very large bio/pharma. I have spoken to some analysts and they are extremely positive but cannot issue notes until the deal is done. I've seen it all before the price action worries small players that this is a bad deal - its not. | czar | |
26/9/2008 08:14 | Very sursprised this is holding up today. Expected it to visit high 30's. | bargainbob | |
26/9/2008 07:40 | Cortez from what I can glean CytoFab could earn substantially more than Varisolve, either of these coming to fruition would justify a market cap of over £1b. | czar | |
25/9/2008 22:27 | bargainbob I disagree. CytoFab is the equal of V earnings wise, maybe 'only' pII but licensed to AZ. Meantime the uncertainty of non-licensed V continues. If 'blockbuster' V fails, the Benefix royalty loss plunges BTG back into the red when the patents expire. Currently 40% of gross BTG royalties are from Benefix and set for growth, making things worse further out. This is solved via CroFab and DigiFab revenues. What's in this shorter term for PTI is what I'm trying to discover. If the combined R&D bill is to be cut by £10m to £20m, can they afford £6m pa R&D for two years of V pIII trials? Seems unlikely. The only thing I can see shorter term that benefits PTI is if V gets licensed. Is this why PTI have done this deal? Baronet 1, Icrammed in as much as possible. | cortez |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions